CO’s First-in-Nation Prescription Drug Price Cap

CO Becomes First State to Cap Prescription Drug Price

On Oct. 3 Colorado’s Prescription Drug Affordability Review Board set an upper payment limit, or UPL, for Enbrel, a prescription drug used to treat rheumatoid arthritis and other autoimmune diseases. The cap—limiting what insurers and patients pay for the medication to no more than about $31,000 per year, nearly half the $53,049 average amount insurance plans paid for the drug in 2023—is the first such limit to be imposed in the nation. (COLORADO SUN)

—Compiled by SNCJ Managing Editor KOREY CLARK

Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.